AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
India's pharmaceutical industry is valued at $50 billion and expected to grow to $120-130 billion by 2030. Generics drive this growth, contributing 70-80% of India's retail pharma revenue. However, concerns about substandard pharmaceuticals in India have been raised by the Central Drugs Standard Control Organisation. Generic medicines are identical to branded drugs in dosage, strength, and effectiveness, but minor differences in inactive ingredients or packaging may exist. Reputable manufacturers follow strict regulatory protocols and conduct bioequivalence studies to ensure safety and effectiveness. Choosing generics can save 30-90% compared to branded medicines.

Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet